Here we test the suitability of one such candidate biomarker, DNA methylation at the ZNF154 locus, for this purpose; we initially discovered methylation near the transcriptional start site of this this gene in a search for a multicancer marker3,4, and it has subsequently been implicated as a tumor suppressor5. This evidence concerns the gene ZNF154 and neoplasm.